Guardant Health (GH) Cash from Financing Activities (2017 - 2026)

Guardant Health (GH) has 10 years of Cash from Financing Activities data on file, last reported at -$21.6 million in Q1 2026.

• Quarterly Cash from Financing Activities rose 67.72% year-over-year to -$21.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $716.4 million (up 1172.91% YoY) and the FY2025 annual result came in at $671.1 million, up 67482.83% from the prior year.
• Cash from Financing Activities retreated to -$21.6 million in Q1 2026 per GH's latest filing, from $732.0 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $732.0 million in Q4 2025, with the low at -$172.1 million in Q2 2022.
• Average Cash from Financing Activities over 5 years is $55.1 million, with a median of -$12000.0 recorded in 2022.
• Year-over-year, Cash from Financing Activities slumped 7016.67% in 2023 and soared 25041.33% in 2025.
• Guardant Health's Cash from Financing Activities stood at $2.3 million in 2022, then jumped by 3807.16% to $90.6 million in 2023, then tumbled by 103.24% to -$2.9 million in 2024, then soared by 25041.33% to $732.0 million in 2025, then plunged by 102.95% to -$21.6 million in 2026.
• Business Quant data shows GH's Cash from Financing Activities at -$21.6 million in Q1 2026, $732.0 million in Q4 2025, and $4.3 million in Q3 2025.